| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $90.6M | +17.1% |
| Cost of Revenue | $69.7M | +16.4% |
| Gross Profit | $20.9M | +19.4% |
| R&D Expense | $1.5M | -19.3% |
| SG&A Expense | $16.7M | -14.1% |
| Operating Income | -$10.8M | +32.3% |
| Pre-tax Income | -$11.6M | +28.9% |
| Income Tax | $41K | -99.8% |
| Net Income | -$11.7M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -67.8% |
| Accounts Receivable | $14.0M | +2.1% |
| Inventory | $18.2M | +0.2% |
| Current Assets | $44.8M | -11.0% |
| Total Assets | $63.2M | -11.7% |
| Current Liabilities | $28.1M | +14.7% |
| Long-term Debt | $10.0M | -0.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | -340.5% |
| Capital Expenditures | $837K | +42.8% |
| Investing Cash Flow | -$731K | +88.2% |
| Financing Cash Flow | -$14K | -100.1% |
| Free Cash Flow | -$10.9M | -279.9% |
| +66.0% |
| EPS (Basic) | -$0.36 | +66.7% |
| EPS (Diluted) | -$0.36 | +66.7% |
| Total Liabilities |
| $40.6M |
| +6.0% |
| Stockholders' Equity | $22.5M | -32.2% |